{"id":"a-101-topical-solution-40","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Dry mouth"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Dizziness"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by reducing sweat gland function, thereby decreasing sweat production. The exact mechanism of action is not fully understood, but it is believed to involve the reduction of sympathetic nervous system activity in the sweat glands.","oneSentence":"A-101 Topical Solution 40% is a topical solution used to treat hyperhidrosis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:20:14.696Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of primary axillary hyperhidrosis"}]},"trialDetails":[{"nctId":"NCT02260180","phase":"PHASE2","title":"Study of A-101 for the Treatment of Seborrheic Keratosis","status":"COMPLETED","sponsor":"Aclaris Therapeutics, Inc.","startDate":"2014-10","conditions":"Seborrheic Keratosis","enrollment":119},{"nctId":"NCT03224598","phase":"PHASE2","title":"A Study of A-101 Topical Solution in Subjects With Dermatosis Papulosa Nigra","status":"COMPLETED","sponsor":"Aclaris Therapeutics, Inc.","startDate":"2017-06-26","conditions":"Dermatosis Papulosa Nigra","enrollment":39},{"nctId":"NCT03487588","phase":"PHASE4","title":"An A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic Keratoses","status":"COMPLETED","sponsor":"Aclaris Therapeutics, Inc.","startDate":"2018-03-21","conditions":"Seborrheic Keratosis","enrollment":41},{"nctId":"NCT02160626","phase":"PHASE2","title":"Dose-Response Profile of A-101 in Subjects With Seborrheic Keratosis","status":"COMPLETED","sponsor":"Aclaris Therapeutics, Inc.","startDate":"2014-06","conditions":"Seborrheic Keratosis","enrollment":172},{"nctId":"NCT01986920","phase":"PHASE1, PHASE2","title":"Study of Safety, Tolerability and Effectiveness of A-101 in Subjects With Seborrheic Keratosis","status":"COMPLETED","sponsor":"Aclaris Therapeutics, Inc.","startDate":"2013-10-22","conditions":"Seborrheic Keratosis (SK)","enrollment":35},{"nctId":"NCT02669862","phase":"PHASE2","title":"A Study of A-101 Solution in Subjects With Common Warts.","status":"COMPLETED","sponsor":"Aclaris Therapeutics, Inc.","startDate":"2015-12-21","conditions":"Common Warts","enrollment":98},{"nctId":"NCT02667288","phase":"PHASE3","title":"An Open-Label Safety Study of A-101 Solution","status":"COMPLETED","sponsor":"Aclaris Therapeutics, Inc.","startDate":"2016-01","conditions":"Seborrheic Keratosis","enrollment":147},{"nctId":"NCT02667275","phase":"PHASE3","title":"A Randomized, Double-Blind, Vehicle-Controlled Study in Subjects With Seborrheic Keratosis","status":"COMPLETED","sponsor":"Aclaris Therapeutics, Inc.","startDate":"2016-01","conditions":"Seborrheic Keratosis","enrollment":487},{"nctId":"NCT02667236","phase":"PHASE3","title":"A Study of A-101 Solution 40% in Subjects With Seborrheic Keratosis.","status":"COMPLETED","sponsor":"Aclaris Therapeutics, Inc.","startDate":"2016-01","conditions":"Seborrheic Keratosis","enrollment":450}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"A-101 Topical Solution 40%","genericName":"A-101 Topical Solution 40%","companyName":"Aclaris Therapeutics, Inc.","companyId":"aclaris-therapeutics-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"A-101 Topical Solution 40% is a topical solution used to treat hyperhidrosis. Used for Treatment of primary axillary hyperhidrosis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}